Oragenics Inc
Change company Symbol lookup
Select an option...
OGEN Oragenics Inc
LOW Lowe's Companies Inc
BAC Bank of America Corp
ECF Ellsworth Growth and Income Fund Ltd
EBF Ennis Inc
EARN Ellington Residential Mortgage REIT
DXC DXC Technology Co
DX Dynex Capital Inc
DVYE iShares Emerging Markets Dividend ETF
DUK Duke Energy Corp
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Oragenics, Inc. is a healthcare company. The Company is focused on developing treatments for oral mucositis and novel antibiotics against infectious disease. The Company is focused on developing of the TerraCoV2 immunization product candidate. The Company’s product candidate includes, OG716, as an antibiotic, as well as other homolog antibiotic product candidates and AG013 for the treatment of oral mucositis in patients undergoing treatment for cancer. The Company have developed other product such as weight loss candidate, LPT3-04 and SMaRT Replacement Therapy.

Closing Price
$0.3941
Day's Change
0.0081 (2.10%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.415
Day's Low
0.39
Volume
(Below Average)
Volume:
4,468,541

10-day average volume:
5,133,302
4,468,541
  • Prev Close
    0.386
  • Today's Open
    0.39
  • Day's Range
    0.39-0.415
  • Avg Vol (10-day)
    5.1M
  • Last (time)
    8:00p ET 11/25/20
  • Last (size)
    300
  • 52-Wk Range
    0.36 - 2.09
    LowHigh
  • (04/16/20 - 07/22/20)
    9.47%
  • 117.3%
  • Market Cap
    24.0M
  • Shares Outstanding
    77.3M
  • -0.50
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • 10.74
  • (% of float 11/13/20)
    3.57

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.